# A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

> **NCT06664502** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **EyeBiotech Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Diabetic Macular Edema (DME)
- Neovascular Age-related Macular Degeneration (NVAMD)
- BRVO - Branch Retinal Vein Occlusion

## Interventions

- **DRUG:** EYE201

## Key facts

- **NCT ID:** NCT06664502
- **Lead sponsor:** EyeBiotech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-12
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-05-31
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06664502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06664502, "A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06664502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*